|
1
|
Lo EH, Dalkara T and Moskowitz MA:
Mechanisms, challenges and opportunities in stroke. Nat Rev
Neurosci. 4:399–415. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Elkind MS: Outcomes after stroke: Risk of
recurrent ischemic stroke and other events. Am J Med. 122 (4 Suppl
2):S7–S13. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Nelson KB: Perinatal ischemic stroke.
Stroke. 38 (2 Suppl):S742–S745. 2007. View Article : Google Scholar
|
|
4
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kosik KS: The neuronal microRNA system.
Nat Rev Neurosci. 7:911–920. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kole AJ, Swahari V, Hammond SM and
Deshmukh M: miR-29b is activated during neuronal maturation and
targets BH3-only genes to restrict apoptosis. Genes Dev.
25:125–130. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yadav S, Pandey A, Shukla A, Talwelkar SS,
Kumar A, Pant AB and Parmar D: MiR-497 and miR-302b regulate
ethanol induced neuronal cell death through BCL2 and cyclin D2. J
Biol Chem. 286:37347–3757. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yin KJ, Deng Z, Huang H, Hamblin M, Xie C,
Zhang J and Chen YE: miR-497 regulates neuronal death in mouse
brain after transient focal cerebral ischemia. Neurobiol Dis.
38:17–26. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jiang Y, Li L, Tan X, Liu B, Zhang Y and
Li C: miR-210 mediates vagus nerve stimulation-induced antioxidant
stress and anti-apoptosis reactions following cerebral
ischemia/reperfusion injury in rats. J Neurochem. 134:173–181.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Shi G, Liu Y, Liu T, Yan W, Liu X, Wang Y,
Shi J and Jia L: Upregulated miR-29b promotes neuronal cell death
by inhibiting Bcl2L2 after ischemic brain injury. Exp Brain Res.
216:225–230. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Clark AM, Goldstein LD, Tevlin M, Tavaré
S, Shaham S and Miska EA: The microRNA miR-124 controls gene
expression in the sensory nervous system of Caenorhabditis elegans.
Nucleic Acids Res. 38:3780–3793. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang Q, Gong Q, Wu Q and Shi J:
Neuroprotective effects of Dendrobium alkaloids on rat cortical
neurons injured by oxygen-glucose deprivation and reperfusion.
Phytomedicine. 17:108–115. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Shi GD, OuYang YP, Shi JG, Liu Y, Yuan W
and Jia LS: PTEN deletion prevents ischemic brain injury by
activating the mTOR signaling pathway. Biochem Biophys Res Commun.
404:941–945. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Peng B, Chen Y and Leong KW: MicroRNA
delivery for regenerative medicine. Adv Drug Deliv Rev. 88:108–122.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bak M, Silahtaroglu A, Møller M,
Christensen M, Rath MF, Skryabin B, Tommerup N and Kauppinen S:
MicroRNA expression in the adult mouse central nervous system. RNA.
14:432–444. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liu DZ, Tian Y, Ander BP, Xu H, Stamova
BS, Zhan X, Turner RJ, Jickling G and Sharp FR: Brain and blood
microRNA expression profiling of ischemic stroke, intracerebral
hemorrhage, and kainate seizures. J Cereb Blood Flow Metab.
30:92–101. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ziu M, Fletcher L, Rana S, Jimenez DF and
Digicaylioglu M: Temporal differences in microRNA expression
patterns in astrocytes and neurons after ischemic injury. PLoS One.
6:e147242011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Schimanski CC, Frerichs K, Rahman F,
Berger M, Lang H, Galle PR, Moehler M and Gockel I: High miR-196a
levels promote the oncogenic phenotype of colorectal cancer cells.
World J Gastroenterol. 15:2089–2096. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tsai KW, Liao YL, Wu CW, Hu LY, Li SC,
Chan WC, Ho MR, Lai CH, Kao HW, Fang WL, et al: Aberrant expression
of miR-196a in gastric cancers and correlation with recurrence.
Genes Chromosomes Cancer. 51:394–401. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liu M, Du Y, Gao J, Liu J, Kong X, Gong Y,
Li Z, Wu H and Chen H: Aberrant expression miR-196a is associated
with abnormal apoptosis, invasion, and proliferation of pancreatic
cancer cells. Pancreas. 42:1169–1181. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Saito K, Inagaki K, Kamimoto T, Ito Y,
Sugita T, Nakajo S, Hirasawa A, Iwamaru A, Ishikura T, Hanaoka H,
et al: MicroRNA-196a is a putative diagnostic biomarker and
therapeutic target for laryngeal cancer. PLoS One. 8:e714802013.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Severino P, Brüggemann H, Andreghetto FM,
Camps C, Klingbeil Mde F, de Pereira WO, Soares RM, Moyses R,
Wünsch-Filho V, Mathor MB, et al: MicroRNA expression profile in
head and neck cancer: HOX-cluster embedded microRNA-196a and
microRNA-10b dysregulation implicated in cell proliferation. BMC
Cancer. 13:5332013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Shah N and Singh I: MicroRNA profiling
identifies miR-196a as differentially expressed in childhood
adrenoleukodystrophy and adult adrenomyeloneuropathy. Mol
Neurobiol. 54:1392–1403. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hong XL, Cao H, Zhao F, Pan XF, Zhang K,
Xu QH, Zhao ZX and Li G: MiR-196a-2 gene polymorphism and the
antiviral therapy of chronic hepatitis C. Zhonghua Shi Yan He Lin
Chuang Bing Du Xue Za Zhi. 24:470–472. 2010.(In Chinese).
PubMed/NCBI
|
|
27
|
Fu MH, Li CL, Lin HL, Tsai SJ, Lai YY,
Chang YF, Cheng PH, Chen CM and Yang SH: The potential regulatory
mechanisms of miR-196a in huntington's disease through
bioinformatic analyses. PLoS One. 10:e01376372015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Shah SN and Resar L: High mobility group
A1 and cancer: Potential biomarker and therapeutic target. Histol
Histopathol. 27:567–579. 2012.PubMed/NCBI
|
|
29
|
Moussavi Nik SH, Newman M and Lardelli M:
The response of HMGA1 to changes in oxygen availability is
evolutionarily conserved. Exp Cell Res. 317:1503–1512. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Xing J, Cao G and Fu C: HMGA1 interacts
with β-catenin to positively regulate Wnt/β-catenin signaling in
colorectal cancer cells. Pathol Oncol Res. 20:847–851. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Treff NR, Pouchnik D, Dement GA, Britt RL
and Reeves R: High-mobility group A1a protein regulates Ras/ERK
signaling in MCF-7 human breast cancer cells. Oncogene. 23:777–785.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Pierantoni GM, Rinaldo C, Mottolese M, Di
Benedetto A, Esposito F, Soddu S and Fusco A: High-mobility group
A1 inhibits p53 by cytoplasmic relocalization of its proapoptotic
activator HIPK2. J Clin Invest. 117:693–702. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Tang D, Kang R, Cheh CW, Livesey KM, Liang
X, Schapiro NE, Benschop R, Sparvero LJ, Amoscato AA, Tracey KJ, et
al: HMGB1 release and redox regulates autophagy and apoptosis in
cancer cells. Oncogene. 29:5299–5310. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Keller JN, Kindy MS, Holtsberg FW, St
Clair DK, Yen HC, Germeyer A, Steiner SM, Bruce-Keller AJ, Hutchins
JB and Mattson MP: Mitochondrial manganese superoxide dismutase
prevents neural apoptosis and reduces ischemic brain injury:
Suppression of peroxynitrite production, lipid peroxidation, and
mitochondrial dysfunction. J Neurosci. 18:687–697. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Chan PH: Reactive oxygen radicals in
signaling and damage in the ischemic brain. J Cereb Blood Flow
Metab. 21:2–14. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kriz J: Inflammation in ischemic brain
injury: Timing is important. Crit Rev Neurobiol. 18:145–157. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Fluiter K, Opperhuizen AL, Morgan BP, Baas
F and Ramaglia V: Inhibition of the membrane attack complex of the
complement system reduces secondary neuroaxonal loss and promotes
neurologic recovery after traumatic brain injury in mice. J
Immunol. 192:2339–2348. 2014. View Article : Google Scholar : PubMed/NCBI
|
